Keywords: takeda, files, alogliptinand, actos, nda, usa, pharmaceutical

Takeda files alogliptinand Actos NDA in USA

Article | 29 September 2008

Print This

Takeda Pharmaceutical's US subsidiary has filed s a New Drug Application with the Food and Drug Administration for alogliptin (SYR-322)/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in